GC says, ‘A man was cured after receiving GC's COVID-19 blood treatment’
상태바
GC says, ‘A man was cured after receiving GC's COVID-19 blood treatment’
  • Kevin Lee 기자
  • 승인 2020.12.08 16:11
  • 댓글 0
이 기사를 공유합니다

GC (Green Cross) is producing COVID-19 blood treatment at its Ochang plant. / Courtesy of GC Green Cross
GC (Green Cross) is producing COVID-19 blood treatment at its Ochang plant. / Courtesy of GC Green Cross

 

GC (Green Cross) said on Dec. 6 that there has been a case of complete recovery after administering COVID-19 blood treatment developed by GC.

The company said that a man in his 70s, who was confirmed to be COVID-19, was completely cured after receiving GC's blood treatment "GC5131A" at Kyungpook National University Hospital in Chilgok in September.

GC has developed a blood treatment called "GC5131A" that divides immune-natured antibodies from the plasma of COVID-19 cured patients and is conducting clinical two-phase tests on patients with high-risk groups.

The patient was not a participant in the clinical trial, but a medical team applied for approval for the use of the treatment to the Ministry of Food and Drug Safety.

He was prescribed anti-viral drugs Remdesibir and steroid drugs Dexamethasone after being tested positive for COVID-19, but medical staff reportedly tried to administer blood-stained drugs because he did not improve.

After about 20 days of treatment, he was finally tested negative on Nov. 18 and was released from quarantine.

A GC spokesman said, "We do not currently have all the data on 13 cases, but it is true that there has been a case of complete recovery among patients who administered blood treatment at Kyungpook National University Hospital in Chilgok."


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.
주요기사